These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20160229)

  • 21. Carrier detection of Batten disease (juvenile neuronal ceroid-lipofuscinosis).
    Taschner PE; de Vos N; Post JG; Meijers-Heijboer EJ; Hofman I; Loonen MC; Pinckers AJ; Bleeker-Wagemakers EM; Gardiner RM; Breuning MH
    Am J Med Genet; 1995 Jun; 57(2):333-7. PubMed ID: 7668358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten disease.
    Rothberg PG; Ramirez-Montealegre D; Frazier SD; Pearce DA
    J Mol Diagn; 2004 Aug; 6(3):260-3. PubMed ID: 15269304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translocation 10;18 in a patient with juvenile neuronal ceroid-lipofuscinosis (Batten disease).
    Tuck-Muller CM; Dyken PR; Li S; Chen H; Labbé E; Wertelecki W
    Am J Med Genet; 1995 Jun; 57(2):168-71. PubMed ID: 7668324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
    Tokola AM; Salli EK; Åberg LE; Autti TH
    Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermediate levels of neuronal palmitoyl-protein Delta-9 desaturase in heterozygotes for murine Batten disease.
    Narayan SB; Tan L; Bennett MJ
    Mol Genet Metab; 2008 Jan; 93(1):89-91. PubMed ID: 17962056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of chromosome 16 markers in the differential diagnosis of neuronal ceroid-lipofuscinosis.
    Taschner PE; de Vos N; Catsman-Berrevoets CE; van Duinen SG; Lindhout D; Breuning MH
    Am J Med Genet; 1995 Jun; 57(2):338-43. PubMed ID: 7668359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid detection of the major deletion in the Batten disease gene CLN3 by allele specific PCR.
    Taschner PE; de Vos N; Breuning MH
    J Med Genet; 1997 Nov; 34(11):955-6. PubMed ID: 9391897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell cycle arrest in Batten disease lymphoblast cells.
    Kang S; Kim JB; Heo TH; Kim SJ
    Gene; 2013 May; 519(2):245-50. PubMed ID: 23458879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The function of CLN3P, the Batten disease protein.
    Rakheja D; Narayan SB; Bennett MJ
    Mol Genet Metab; 2008 Mar; 93(3):269-74. PubMed ID: 18688960
    [No Abstract]   [Full Text] [Related]  

  • 33. A variant form of late infantile neuronal ceroid lipofuscinosis (CLN5) is not an allelic form of Batten (Spielmeyer-Vogt-Sjögren, CLN3) disease: exclusion of linkage to the CLN3 region of chromosome 16.
    Williams R; Santavuori P; Peltonen L; Gardiner RM; Järvelä I
    Genomics; 1994 Mar; 20(2):289-90. PubMed ID: 8020979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotic symptoms in frontotemporal dementia: prevalence and review.
    Mendez MF; Shapira JS; Woods RJ; Licht EA; Saul RE
    Dement Geriatr Cogn Disord; 2008; 25(3):206-11. PubMed ID: 18204254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Adams HR; Mink JW;
    J Child Neurol; 2013 Sep; 28(9):1128-36. PubMed ID: 24014508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The molecular etiology of neuronal ceroid lipofuscinosis].
    Järvelä I; Hellsten E; Vesa J; Palotie L
    Duodecim; 1996; 112(13):1139-41. PubMed ID: 10596080
    [No Abstract]   [Full Text] [Related]  

  • 37. Mapping the gene for juvenile onset neuronal ceroid lipofuscinosis to chromosome 16 by linkage analysis.
    Gardiner RM
    Am J Med Genet; 1992 Feb; 42(4):539-41. PubMed ID: 1351702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage analysis in juvenile neuronal ceroid lipofuscinosis.
    Haines JL; Yan WL; Boustany RM; Jewell A; Julier C; Breakefield XO; Gusella JF
    Am J Med Genet; 1992 Feb; 42(4):542-5. PubMed ID: 1609835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Juvenile neuronal ceroid lipofuscinosis.
    Gulati S; Maheshwari R; Kabra M; Verma IC; Kalra V
    Indian J Pediatr; 2000 Sep; 67(9):689-91. PubMed ID: 11028125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revelation of a novel CLN5 mutation in early juvenile neuronal ceroid lipofuscinosis.
    Cannelli N; Nardocci N; Cassandrini D; Morbin M; Aiello C; Bugiani M; Criscuolo L; Zara F; Striano P; Granata T; Bertini E; Simonati A; Santorelli FM
    Neuropediatrics; 2007 Feb; 38(1):46-9. PubMed ID: 17607606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.